ACN
Accenture plc
ACN's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over ACN overall, supported by stronger modeled upside and stronger fundamentals.
ACN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ACN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
ACN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $250 | — |
| Current | 18x | $250 | — |
| Cheap | 21x | $285 | +14% |
| Fair | 28x | $381 | +52% |
| Expensive | 33x | $447 | +79% |
Historical ranges are pointers, not guarantees.
ACN has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
ACN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for ACN, with profitability holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over ACN on the outlook, with more favorable profitability expectations.
ACN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.67 | +8.2% |
| Q3 2026 | $13.56 | +12% |
| Q2 2026 | $12.52 | -0.3% |
| Q1 2026 | $12.21 | +0.8% |
| Q4 2025 | $12.10 | +1.5% |
| Q3 2025 | $12.15 | +6.3% |
| Q2 2025 | $12.56 | +15% |
| Q1 2025 | $12.11 | +9.8% |
| Q4 2024 | $11.92 | +10% |
ACN earned $13.56 per share over the past year, up 12% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over ACN on earnings, with more consistent year-over-year improvement.
ACN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +6.2% |
| Q2 2026 | $18.7B | +5.6% |
| Q1 2026 | $18B | +8.3% |
| Q4 2025 | $18.7B | +6% |
| Q3 2025 | $17.6B | +7.3% |
| Q2 2025 | $17.7B | +7.7% |
| Q1 2025 | $16.7B | +5.4% |
| Q4 2024 | $17.7B | +9% |
ACN's revenue has grown year over year for nine quarters in a row: $18.7B last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.7 points |
| Q2 2026 | 17% | +0.1 points |
| Q1 2026 | 14% | +0.3 points |
| Q4 2025 | 15% | -1.3 points |
| Q3 2025 | 12% | -2.7 points |
| Q2 2025 | 17% | +0.8 points |
| Q1 2025 | 13% | +0.5 points |
| Q4 2024 | 17% | +0.9 points |
ACN's operating margin was 15% last quarter, up 3.7 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over ACN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over ACN on profitability, with a higher operating margin.
ACN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8B | -25% |
| Q2 2026 | $3.6B | +2.4% |
| Q1 2026 | $3.7B | +37% |
| Q4 2025 | $1.5B | +73% |
| Q3 2025 | $3.8B | +20% |
| Q2 2025 | $3.5B | +16% |
| Q1 2025 | $2.7B | +35% |
| Q4 2024 | $870.3M | +103% |
ACN's free cash flow has been positive every quarter for seven years: $11.6B over the past year, up 6.9% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
ACN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -10.3M shares |
| 1 year | -3.8% | -24.1M shares |
| 3 years | -5.3% | -34M shares |
| 5 years | -6.2% | -40M shares |
| Available history | -6.8% | -44.1M shares |
ACN has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.3B |
| Q2 2026 | $1.2B |
| Q1 2026 | $1.7B |
| Q4 2025 | $2.3B |
| Q3 2025 | $473.9M |
| Q2 2025 | $1.8B |
| Q1 2025 | $1.4B |
| Q4 2024 | $898.3M |
ACN spent $7.5B buying back its own shares over the past year, up 63% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
ACN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
ACN has more cash than debt.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over ACN on leverage, with a lower net debt burden relative to earnings.
ACN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 88.9 | Overbought |
ACN's weekly RSI is 68 (neutral) and its Stochastic is 89 (overbought).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
ACN PE vs Technology Sector
| Metric | ACN | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 34% below |
| PE % | 10 | 35 | 25 pts below |
ACN is trading at 18x earnings, a 34% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over ACN on valuation relative to its sector.
ACN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.0 | 9.2% above |
| 20 week MA | $192.0 | 30% above |
| 50 week MA | $204.9 | 22% above |
| 100 week MA | $250.4 | 0.2% below |
| 200 week MA | $285.4 | 12% below |
ACN has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 12% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
ACN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $212.2 | $257.3 | +21% |
| 2021 | $257.3 | $403.3 | +57% |
| 2022 | $403.3 | $266.1 | -34% |
| 2023 | $266.1 | $350.9 | +32% |
| 2024 | $350.9 | $356.2 | +1.5% |
| 2025 | $356.2 | $271.1 | -24% |
| 2026 YTD | $271.1 | $250.0 | -7.8% |
ACN has finished higher in four of the last six years. It's down 7.8% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over ACN on returns for 2026, with the stronger performance.